Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering a theranostic platform for synergistic hypoxia-responsive photodynamic therapy and chemotherapy
Jianhua Xiong, Pengzhan Wang, Subin Son, et al.
Matter (2022) Vol. 5, Iss. 5, pp. 1502-1519
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Theranostic Fluorescent Probes
Amit Sharma, Peter Verwilst, Mingle Li, et al.
Chemical Reviews (2024) Vol. 124, Iss. 5, pp. 2699-2804
Open Access | Times Cited: 132
An Activity‐Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO−) in the Alzheimer's Disease Brain
Pengzhan Wang, Le Yu, Jiankang Gong, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 36
Closed Access | Times Cited: 118
From Low to No O2-Dependent Hypoxia Photodynamic Therapy (hPDT): A New Perspective
Mingle Li, Yunjie Xu, Xiaojun Peng, et al.
Accounts of Chemical Research (2022) Vol. 55, Iss. 22, pp. 3253-3264
Closed Access | Times Cited: 106
Engineering of BODIPY-based theranostics for cancer therapy
Zhiqiang Mao, Ji Hyeon Kim, Jieun Lee, et al.
Coordination Chemistry Reviews (2022) Vol. 476, pp. 214908-214908
Closed Access | Times Cited: 101
Oxygen-independent organic photosensitizer with ultralow-power NIR photoexcitation for tumor-specific photodynamic therapy
Yufu Tang, Yuanyuan Li, Bowen Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Pore-engineered nanoarchitectonics for cancer therapy
Linawati Sutrisno, Katsuhiko Ariga
NPG Asia Materials (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 28
Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies
Xia Wang, Jinlei Peng, Chi Meng, et al.
Chemical Science (2024) Vol. 15, Iss. 31, pp. 12234-12257
Open Access | Times Cited: 17
Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single‐Component Organic Phototherapeutic Agents
Laiping Fang, Zengzhen Chen, Jianan Dai, et al.
Advanced Science (2025)
Open Access | Times Cited: 3
Hypoxia-Activated PEGylated Paclitaxel Prodrug Nanoparticles for Potentiated Chemotherapy
Dengyuan Hao, Qian Meng, Bowen Jiang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14693-14702
Closed Access | Times Cited: 53
THQ–Xanthene: An Emerging Strategy to Create Next‐Generation NIR‐I/II Fluorophores
Zhiqiang Mao, Hyeonji Rha, Jungryun Kim, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 39
A Tumor‐Microenvironment‐Activatable Molecular Pro‐Theranostic Agent for Photodynamic and Immunotherapy of Cancer
Hui Zhou, Yuan Zhang, Ruru Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 30
Closed Access | Times Cited: 37
Bioorthogonal Strategy-Triggered In situ Co-Activation of Aggregation-Induced Emission Photosensitizers and Chemotherapeutic Prodrugs for Boosting Synergistic Chemo-Photodynamic-Immunotherapy
Yu Teng, Dianyu Wang, Wenlong Yang, et al.
Biomaterials (2025) Vol. 317, pp. 123092-123092
Closed Access | Times Cited: 1
A Hypoxia-Activated BODIPY-Azo Anticancer Prodrug for Bimodal Chemo-Photodynamic Therapy
Ting Zhang, Baoyin Yang, Tao Jiang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Computational Biomaterials: Computational Simulations for Biomedicine
Xinyue Dai, Yu Chen
Advanced Materials (2022) Vol. 35, Iss. 7
Closed Access | Times Cited: 30
Stimuli‐Responsive Prodrug Chemistries for Cancer Therapy
Rupa Bargakshatriya, Sumit Kumar Pramanik
ChemBioChem (2023) Vol. 24, Iss. 18
Closed Access | Times Cited: 21
Enhancing the Selectivity of Leucine Aminopeptidase Near-Infrared Fluorescent Probes for Assisting in Surgical Tumor Resection
Rongbin Zhong, Renfeng Jiang, Jiayu Zeng, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 4, pp. 2428-2435
Closed Access | Times Cited: 20
Activatable Phototherapeutic Prodrug Conquering Hypoxia Limitation to Enhance Chemical Drug Delivery Efficiency
Jianhua Xiong, Weijie Chi, Miantai Ye, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 7, pp. 2548-2558
Closed Access | Times Cited: 7
A GSH-activated AIE-based polymer photosensitizer for killing cancer cells
Wei Lang, Lizhen Chen, Yong Chen, et al.
Talanta (2023) Vol. 258, pp. 124473-124473
Closed Access | Times Cited: 16
Tumor‐Activated Prodrug with Synergistic Anti‐Stemness Chemical and Photodynamic Therapies
Jianhua Xiong, Xiaoyu Wang, Jaewon Kim, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 10
Closed Access | Times Cited: 14
A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis
Ji Hyeon Kim, Jung Min Park, Eunsun Jung, et al.
Biomaterials (2022) Vol. 289, pp. 121781-121781
Closed Access | Times Cited: 19
A Selenium‐Substituted Heptamethine Cyanine Photosensitizer for Near‐Infrared Photodynamic Therapy
Jinghan Sun, Erting Feng, Yutong Shao, et al.
ChemBioChem (2022) Vol. 23, Iss. 22
Closed Access | Times Cited: 19
Hypoxia-Activated Theragnostic Prodrugs (HATPs): Current State and Future Perspectives
Sankarprasad Bhuniya, Eirinaios I. Vrettos
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 557-557
Open Access | Times Cited: 4
Smart molecular designs and applications of activatable organic photosensitizers
Eleni Nestoros, Amit Sharma, Eunji Kim, et al.
Nature Reviews Chemistry (2024)
Closed Access | Times Cited: 4
Synergistic Cancer Therapy: An NIR-Activated Methylene Blue-Nitrogen Mustard Prodrug for Combined Chemotherapy and Photodynamic Therapy
Tianyu Zhu, Jipeng Ding, Fan Zheng, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Page 1 - Next Page

Scroll to top